Invention Application
- Patent Title: 2-ARYL- AND 2-HETEROARYL-SUBSTITUTED 2-PYRIDAZIN-3(2H)-ONE COMPOUNDS AS INHIBITORS OF FGFR TYROSINE KINASES
-
Application No.: US15333148Application Date: 2016-10-24
-
Publication No.: US20170260168A1Publication Date: 2017-09-14
- Inventor: Steven W. Andrews , James F. Blake , Adam Cook , Indrani W. Gunawardana , Kevin W. Hunt , Andrew T. Metcalf , David Moreno , Li Ren , Tony P. Tang
- Applicant: Array BioPharma, Inc.
- Main IPC: C07D403/14
- IPC: C07D403/14 ; A61K31/501 ; G01N33/574 ; A61K31/5377 ; C07D401/14 ; C12Q1/68 ; A61K45/06 ; C07D413/14
Abstract:
Provided herein are compounds of the general Formula I: and stereoisomers and pharmaceutically acceptable salts or solvates thereof, in which X, R1, R2, R3, Ring A and z have the meanings given in the specification, which are inhibitors of FGFR1, FGFR2, FGFR3 and/or FGFR4 and are useful in the treatment and prevention of diseases which can be treated with an FGFR inhibitor, including diseases or disorders mediated by FGFR1, FGFR2, FGFR3 and/or FGFR4.
Public/Granted literature
- US10208024B2 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases Public/Granted day:2019-02-19
Information query
